aedifica

Company posts

Admission of new shares to trading – New denominator – Appointment of new Directors

Aedifica NV/SA hat die Zulassung neuer Aktien zum Handel bekanntgegeben. Zudem wurden neue Direktoren ernannt.

Aedifica NV/SA: 2025 annual results

While an ageing European population is driving the need for additional healthcare real estate capacity and market sentiment is changing, Aedifica demonstrated in 2025 that it is ready to meet the moment.